Globe Life INC

Globe Life Inc. announced robust second quarter 2026 financial results, with net income per diluted share rising 20% and net operating income per diluted share increasing 10% year-over-year, prompting an increase in full-year earnings guidance.

Globe Life Inc. has entered into a Third Amended and Restated Credit Agreement and an Amended and Restated Term Loan Agreement, extending maturity dates and increasing loan amounts.

Globe Life Inc. reports results from its Annual Meeting of Shareholders, including director elections and advisory votes on executive compensation and incentive plans.

Globe Life reported strong Q1 2026 results with a 13% increase in net income per share and raised its full-year 2026 earnings guidance.

Globe Life Inc. has expanded its Board of Directors from twelve to fourteen members, appointing Derek T. Kan and Sandra L. Phillips as independent directors.

Globe Life Inc. announced robust fourth quarter and full-year 2025 financial results, with net operating income per diluted common share surpassing previous guidance.

Globe Life Inc. announced a 6% increase in total premium and a 13% rise in health premium for the first quarter of 2026, with net income reaching $271 million.

Globe Life Inc. reports robust Q3 2025 financial results with significant net income growth, increased premiums, and continued share repurchases.

Globe Life Inc. reports increased diluted earnings per share and book value driven by share repurchases, while two major regulatory investigations conclude without enforcement action.

Globe Life's Q1 2025 results show a slight increase in net income and a focus on growing its life insurance segment while managing health insurance costs and investment yields.

Globe Life Inc. announced a 17% increase in net income and a 5% rise in total premium for the nine months ended September 30, 2024, showcasing robust financial performance.

Globe Life Inc. announced a 17% increase in net income for the first half of 2024, driven by premium growth and strong investment performance.

Globe Life Inc. announced robust financial results for 2025, with net income and total premiums increasing, while navigating ongoing litigation and market shifts.

Globe Life Inc. announces a 10% increase in net income for 2024, fueled by growth in premiums and net investment income.

Globe Life Inc. files its 10-K report for 2023, detailing financial results, stock option grants, and business operations.

James Matthew Darden, Co-Chairman & CEO and a Director of Globe Life Inc., sold 50,000 shares of common stock on July 31, 2026.

Thomas Peter Kalmbach, EVP & CFO of Globe Life Inc., sold 21,000 shares of common stock on July 30, 2026.

Michael Clay Majors, EVP - Chief Strategy Officer of Globe Life Inc., sold 37,000 shares of common stock on July 29, 2026.

Thomas Peter Kalmbach, EVP & CFO of Globe Life Inc., sold 25,650 shares of common stock on July 28, 2026.

Globe Life Inc. reports insider trading activity where EVP Dolores L. Skarjune sold 1,850 shares of common stock.

Globe Life Inc. Director Cheryl Alston reported transactions involving the acquisition and disposition of company common stock on June 25, 2026.

Globe Life Inc. details the schedule and proposals for its 2025 Annual Meeting of Shareholders, emphasizing virtual attendance and advance voting.

Globe Life Inc. will hold its 2024 Annual Meeting of Shareholders virtually on April 25, 2024, to vote on director elections, auditor ratification, and executive compensation.

Globe Life Inc. reported 2 holdings worth $421.6M for the period ended June 30, 2026.

Globe Life Inc. discloses its Q1 2026 investment holdings, primarily in Vanguard funds, with a total portfolio value of $380.8 million.

Globe Life Inc. has filed its Form 13F-HR, revealing its equity holdings as of December 31, 2025, totaling $397.8 million across two Vanguard mutual funds.

Globe Life Inc. filed its Q3 2025 13F-HR report, detailing its institutional investment holdings, primarily in Vanguard mutual funds.

Globe Life Inc. reported its second-quarter 2025 equity holdings, totaling over $365 million across two Vanguard mutual funds.

Globe Life Inc.'s latest 13F filing reveals its holdings as of March 31, 2025, totaling $340.2 million across two Vanguard funds.

Invesco Ltd. has reported beneficial ownership of 5.1% of Globe Life Inc.'s common stock as of March 31, 2026.

Vanguard Capital Management has reported beneficial ownership of 7.45% of Globe Life Inc.'s common stock as of March 31, 2026.

Vanguard Portfolio Management has reported beneficial ownership of 5.44% of Globe Life Inc.'s common stock as of March 31, 2026.

The Vanguard Group has amended its Schedule 13G for Globe Life Inc., reporting zero beneficial ownership following an internal realignment that disaggregates reporting to its subsidiaries.

The Vanguard Group reported a 12.67% beneficial ownership in Globe Life Inc. common stock as of December 31, 2025, following an internal realignment.

Wellington Management Group and its affiliates reported a 4.79% beneficial ownership stake in Globe Life Inc. common stock as of June 30, 2025.